Upload Avatar (500 x 500)
Hongyang Wang
hywangk@vip.sina.com
Chinese, English, German
Shanghai
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 1989.06-1992.09 PhD in Clinical Biochemistry: University of Ulm
  • Academician of the Chinese Academy of Engineering
  • Academician of the World Academy of Sciences for the advancement of science in developing countries
  • Founder Director of the National Liver Cancer Science Center
  • Published over 300 papers in influential journals like Cell, Cancer Cell, Science Translational Medicine
  • Received 14 invention patents in the last five years
  • 2013.02-present - National Liver Cancer Science Center - Director
  • Wu Jieping Medical Award (2021): Wu Jieping Medical Foundation
  • National Innovation Award Medal (2020): Ministry of Human Resources and Social Security, China Association for Science and Technology, Ministry of Science and Technology, State-owned Assets Supervision and Administration Commission of the State Council
  • Shanghai Medical Development Outstanding Contribution Award (2017): Shanghai Medical Association
  • Second Tree-Lan Medical Award (2015): Shusen-Lanjuan Academician Talent Fund Council
  • New Discovery of Molecular Mechanism of Malignant Transformation of Liver Inflammation (2014): Shanghai Municipal Government
Molecular mechanisms and regulatory networks promoting tumorigenesis and development in inflammation and metabolism
Signal regulation of cancer stem cells and its significance in hepatobiliary tumors
Early diagnosis, molecular typing, and personalized treatment of tumors (digestive system tumors, urinary system tumors, etc.)
  • The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis., Hongyang Wang* et al., 2023
  • Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma., Hongyang Wang* et al., 2023
  • PTEN Deficiency Facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis., Hongyang Wang* et al., 2023
  • To be or not to be: The double-edged sword roles of liver progenitor cells., Hongyang Wang* et al., 2023
  • m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway., Hongyang Wang* et al., 2023
  • Development of a TMErisk model based on immune infiltration in tumour microenvironment to predict prognosis of immune checkpoint inhibitor treatment in hepatocellular carcinoma., Hongyang Wang* et al., 2023
  • Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma., Hongyang Wang* et al., 2022
  • Integrated Multi-Omics Landscape of Liver Metastases., Hongyang Wang* et al., 2022
Tumorigenesis Inflammation Metabolism Molecular Mechanisms Regulatory Networks Cancer Stem Cells Hepatobiliary Tumors Early Diagnosis Molecular Typing Personalized Treatment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.